Inhibikase Therapeutics, Inc.
$18 M
IPO
Sole Book-Runner
Virios Therapeutics, Inc.
$34.5 M
IPO
Sole Book-Runner
ENDRA Life Sciences Inc.
$5.5 M
Follow-On Offering
Sole Book-Runner
cbdMD, Inc.
$17.3 M
8% Series A Cumulative Convertible Preferred Stock
Sole Book-Runner
Nano Dimension Ltd.
$180 M
Registered Direct
Sole Placement Agent
Nano Dimension Ltd.
$60 M
Registered Direct
Sole Placement Agent
Hepion Pharmaceuticals, Inc.
$34.5 M
Follow-On Offering
Sole Book-Runner
Vision Marine Technologies Inc.
$27.6 M
IPO
Sole Book-Runner
Nano Dimension Ltd.
$100 M
Registered Direct
Sole Placement Agent
Nano Dimension Ltd.
$50.2 M
Registered Direct
Sole Placement Agent
Piedmont Lithium Ltd.
$57.5 M
Follow-On Offering
Joint Book-Runner
Kiromic BioPharma, Inc.
$15 M
IPO
Sole Book-Runner